Beta-carbolines as specific inhibitors of cyclin-dependent kinases

Bioorg Med Chem Lett. 2002 Apr 8;12(7):1129-32. doi: 10.1016/s0960-894x(02)00094-x.

Abstract

Harmine (3), 7-fluoro-1-methyl beta-carboline (35) and 1-(5-methyl-imidazol-4-yl) beta-carboline (41) were potent and specific inhibitors of cyclin-dependent kinases. The degree of aromaticity of the tricyclic ring and the positioning of substituents are important for inhibitory activity. While most beta-carbolines inhibited CDK2 and CDK5 to the same extent, selective inhibition against CDK2 was observed in 1-(2-chlorophenyl)- (12), 1-(2-fluorophenyl)- (15), and 1-(2-chloro-5-nitrophenyl)- (28) beta-carbolines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CDC2-CDC28 Kinases*
  • Carbolines / pharmacology*
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinase 5
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclin-Dependent Kinases / antagonists & inhibitors*
  • Cyclins / pharmacology*
  • Protein Serine-Threonine Kinases / antagonists & inhibitors*

Substances

  • Carbolines
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Cyclin-Dependent Kinase 5
  • Protein Serine-Threonine Kinases
  • CDC2-CDC28 Kinases
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinases